Clinical trial
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
NCT07758231 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- March 31, 2027
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol, glp-1